Systemic distribution of miR-34a in carriers of liposomes resulted in lower growth of the tumor, enhanced tumor cell death, and reduced CD44+ cell numbers in a model of orthotopic pancreatic cancer employing cells of MiaPaca2, depicting a reduction in metastatic cells [31]. The gene discussed is CD44; the disease is neoplasm.